Interview with Diana Valencia, Executive Director, LatAm Clinical Trials
While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a business unit of…
Address: Av. 9 No. 123-86 / Of. 703 Bogotá D.C. Colombia
Tel: (571) 6203530
Web: http://www.latamtrials.com/
Latam Clinical Trials specializes in conducting superior Phase I-IV clinical trials in Latin America, specifically in the Andean Region, Central America and the Caribbean, offering our three services lines: Conducting and Monitoring Clinical trials, Management of Regulatory Issues, and training.
Latam Clinical Trials has business development offices in the USA and clinical staff located in the Andean Countries of South America and in Central America, giving access to substantial underutilized medical expertise and infrastructure throughout an area that includes Ecuador, Colombia, Peru, Panama and Venezuela.
Latam Clinical Trials’ geographic reach is extended to additional countries in Latin America through partnerships with other local CROs in Mexico, Argentina and Brazil
Regulatory Support and Submission, Patient Recruitment Management, Project Management
While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a business unit of…
Gustavo Morales, Executive Director of the Association of Pharmaceutical Research and Development Laboratories (AFIDRO) and proud advocate of intellectual property has successfully changed Colombian public opinion on the pharmaceutical industry.…
In explaining the role of the Colombia National Food and Drug Surveillance Institute (INVIMA) and its impact on the regulatory landscape of the healthcare sector, Javier Guzman, Executive Director, centres…
Héctor Robles, General Manager of Laboratorios Sophia, a leading ophthalmology company, discusses the significant growth of the Colombian affiliate to become an operational center for the Andean region. Additionally, he…
Héctor Castro, director of Medicines and Health Technologies at the Colombian Ministry of Health since 2016, explains how the regulations and quality standards implemented have contributed to make Colombia’s healthcare…
Juan Gabriel Pérez, Executive Director of Invest in Bogota, shares his powerful message of why Bogota is an ideal investment destination, not only relative to other Colombian cities, but to…
Aurobindo’s regional head, Kamlesh Thakkar, discusses how the company is truly benefiting the healthcare landscape in Colombia, while describing his experience in changing the mindset concerning the use of generics…
Regional leader of Boston Scientific’s Andean Region, Fernando Dussan, share his insights on why Colombia is suitable to host the core business of Boston Scientific. He speaks about the company’s…
Spearheading the Colombian affiliate of the global leader in oncology, Carlos Estrada, General Manager of Roche Colombia shares his insights on the profound transformations of the Colombian healthcare system. He…
The executive director of the AmCham Colombia shares his insights on the legacy of strong economic ties between the two countries. He speaks about the changing socio-political landscape of Colombia,…
Executive Director of the French-Colombian Chamber of Commerce and Industry, Victor Brun, shares his insights regarding the solid Franco-Colombo relations. He speaks about the synergies between the two cultures, the…
PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times LatAm Healthcare & Life Sciences Summit in September 2015. He emphasizes the criticality of…
The founder and general manager of Biotechnova considers the potential of Colombia for biotechnological innovation, and explains the current state of the biogeneric industry in Latin America. Please start by…
See our Cookie Privacy Policy Here
